All News

Allogeneic

Shining the Spotlight on Texas Biotech Companies
30 October 2024
Shining the Spotlight on Texas Biotech Companies
ATW 2025 is taking place
Partnering to Enable Solutions for Allogeneic Cell Therapy Industrialization
18 April 2024
Partnering to Enable Solutions for Allogeneic Cell Therapy Industrialization
Aaron Dulgar-Tulloch, Chief Technology Officer,
Revolutionizing Regenerative Medicine: Exploring the Promise and Challenges of Allogeneic Therapies
28 November 2023
Revolutionizing Regenerative Medicine: Exploring the Promise and Challenges of Allogeneic Therapies
David Sourdive joins us in
Beam Therapeutics Announced First Patient Dosed in Phase I/II Trial in Relapsed, Refractory T-ALL/T-LL
6 September 2023
Beam Therapeutics Announced First Patient Dosed in Phase I/II Trial in Relapsed, Refractory T-ALL/T-LL
Beam Therapeutics Announced First Patient
POPULAR NEWS ITEMS
Image
26 November 2024

ATW Speaker Patrick M Gailliot Previews Event and Discusses His Role in Autologous Cell and Gene Therapies

Image
19 November 2024

Texas Cell and Gene Manufacturing Landscape

Image
12 November 2024

Full Agenda Released for Advanced Therapies Week 2025 in Dallas

Cellares Raises $255M Series C to Launch First Integrated Development and Manufacturing Organization
24 August 2023
Cellares Raises $255M Series C to Launch First Integrated Development and Manufacturing Organization
Cellares has secured $255 million
Precision BioSciences Completes Strategic $227M Transaction with Imugene for CAR-T Therapy
17 August 2023
Precision BioSciences Completes Strategic $227M Transaction with Imugene for CAR-T Therapy
Precision BioSciences Completes Strategic Transaction
Kyverna’s Series B Financing Round Extends to $145M
3 August 2023
Kyverna’s Series B Financing Round Extends to $145M
Kyverna Therapeutics has oversubscribed its
First Type 1 Diabetes Cell Therapy Approved by the FDA
28 July 2023
First Type 1 Diabetes Cell Therapy Approved by the FDA
The FDA has approved the
Load more News
RECOMENDED TOPICS
Allogeneic
Autologous
CAR-X
Cell Therapy
Cell-Based IO
Gene Editing
Gene Therapy
NKx
Stem Cells
Tissue Engineering
Viral/Non-Viral Vectors
POPULAR NEWS ITEMS
Image

ATW Speaker Patrick M Gailliot Previews Event and Discusses His Role in Autologous Cell and Gene Therapies

Image

Texas Cell and Gene Manufacturing Landscape

Image

Full Agenda Released for Advanced Therapies Week 2025 in Dallas